Laboratory assays in pediatric endocrinology: common aspects

Endocrinologists face a growing number of diagnostic tests but lack guidance on evaluating their reliability. Prior research has shown that analytical validation ensures sensitivity and specificity in assays. However, no prior work had resolved how to apply these standards in clinical settings. Clinical validation remains poorly understood in many cases. Reference intervals for endocrine tests vary widely across methods. This gap motivated the need for clearer guidelines on assay interpretation. Antibody-based assays present unique challenges depending on their design. Mass spectrometry offers new opportunities but also introduces new complexities.

The goal is to clarify how endocrinologists can assess laboratory assays for diagnostic use. Clinicians must understand both analytical and clinical validation processes. The study addresses how assay design affects result interpretation. It highlights the differences between competitive and non-competitive assays. The paper also explores the role of mass spectrometry in endocrine testing. Reference intervals are examined for their limitations in diagnosis. Collaboration between clinicians and labs is emphasized for better thresholds. The focus is on practical application rather than theoretical models.

The approach involves a review of analytical validation standards for endocrine assays. Clinical validation is analyzed in relation to specific patient scenarios. Competitive and non-competitive antibody assays are compared for signal interpretation. Mass spectrometry is reviewed for its advantages and limitations. Reference interval determination methods are evaluated for consistency. The paper synthesizes literature on assay interference effects. Clinical thresholds are discussed in the context of diagnostic accuracy. The review emphasizes the need for interdisciplinary collaboration.

Analytical validation ensures sensitivity and specificity in assays. Clinical validation is essential for applying results to real-world cases. Competitive assays show increased analyte when signal is reduced. Non-competitive assays show decreased analyte with reduced signal. Mass spectrometry provides high accuracy but requires careful interpretation. Reference intervals differ based on the method used for determination. Overreliance on reference intervals may lead to misdiagnosis. Clinical thresholds require input from both clinicians and laboratory experts.

Endocrinologists must evaluate both analytical and clinical validation when using assays. Competitive and non-competitive assays behave differently with interference. Mass spectrometry offers precision but introduces new challenges. Reference intervals alone may not be sufficient for diagnosis. Clinical thresholds should be developed through clinician-laboratory collaboration. The authors suggest that understanding assay design is crucial for accurate interpretation. They propose that diagnostic decisions require more than just reference ranges. The study emphasizes the importance of interdisciplinary communication.